Potentiation of the anti-tumour effects of Photofrin®-based photodynamic therapy by localized treatment with G-CSF

Photofrin®-based photodynamic therapy (PDT) has recently been approved for palliative and curative purposes in cancer patients. It has been demonstrated that neutrophils are indispensable for its anti-tumour effectiveness. We decided to evaluate the extent of the anti-tumour effectiveness of PDT combined with administration of granulocyte colony-stimulating factor (G-CSF) as well as the influence of Photofrin®and G-CSF on the myelopoiesis and functional activity of neutrophils in mice. An intensive treatment with G-CSF significantly potentiated anti-tumour effectiveness of Photofrin®-based PDT resulting in a reduction of tumour growth and prolongation of the survival time of mice bearing two different tumours: colon-26 and Lewis lung carcinoma. Moreover, 33% of C-26-bearing mice were completely cured of their tumours after combined therapy and developed a specific and long-lasting immunity. The tumours treated with both agents contained more infiltrating neutrophils and apoptotic cells then tumours treated with either G-CSF or PDT only. Importantly, simultaneous administration of Photofrin®and G-CSF stimulated bone marrow and spleen myelopoiesis that resulted in an increased number of neutrophils demonstrating functional characteristics of activation. Potentiated anti-tumour effects of Photofrin®-based PDT combined with G-CSF observed in two murine tumour models suggest that clinical trials using this tumour therapy protocol would be worth pursuing. © 2000 Cancer Research Campaign

[1]  M. Korbelik,et al.  Photodynamic therapy-mediated immune response against subcutaneous mouse tumors. , 1999, Cancer research.

[2]  Loise M. Francisco,et al.  Immature Dendritic Cells Phagocytose Apoptotic Cells via αvβ5 and CD36, and Cross-present Antigens to Cytotoxic T Lymphocytes , 1998, The Journal of experimental medicine.

[3]  M. Colombo,et al.  Interferon γ–independent Rejection of Interleukin 12–transduced Carcinoma Cells Requires CD4+ T Cells and Granulocyte/Macrophage Colony–stimulating Factor , 1998, The Journal of Experimental Medicine.

[4]  R. Agarwal,et al.  Photodynamic therapy results in induction of WAF1/CIP1/P21 leading to cell cycle arrest and apoptosis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[5]  A. Dabrowska,et al.  Granulocyte-Macrophage Colony-Stimulating Factor Potentiates Antitumor Activity of Interleukin-12 in Melanoma Model in Mice , 1998, Tumor Biology.

[6]  A. Dabrowska,et al.  G-CSF prevents the suppression of bone marrow hematopoiesis induced by IL-12 and augments its antitumor activity in a melanoma model in mice. , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

[7]  J. Levy,et al.  Photofrin increases murine spleen cell transferrin receptor expression and responsiveness to recombinant myeloid and erythroid growth factors. , 1998, Immunopharmacology.

[8]  T. Wieman,et al.  The Effects of Thrombocytopenia on Vessel Stasis and Macromolecular Leakage after Photodynamic Therapy Using Photofrin , 1997, Photochemistry and photobiology.

[9]  J. Levy,et al.  Photodynamic therapy induces caspase-3 activation in HL-60 cells , 1997, Cell Death and Differentiation.

[10]  M. Ochsner Photophysical and photobiological processes in the photodynamic therapy of tumours. , 1997, Journal of photochemistry and photobiology. B, Biology.

[11]  T Reynolds,et al.  Photodynamic therapy expands its horizons. , 1997, Journal of the National Cancer Institute.

[12]  M. Korbelik,et al.  Macrophage-directed immunotherapy as adjuvant to photodynamic therapy of cancer. , 1997, British Journal of Cancer.

[13]  J. Krosl,et al.  The role of host lymphoid populations in the response of mouse EMT6 tumor to photodynamic therapy. , 1996, Cancer research.

[14]  M. Korbelik,et al.  Induction of tumor immunity by photodynamic therapy. , 1996, Journal of clinical laser medicine & surgery.

[15]  J. Gabrilove,et al.  Filgrastim (r-metHuG-CSF): the first 10 years. , 1996, Blood.

[16]  J. Krosl,et al.  Potentiation of photodynamic therapy-elicited antitumor response by localized treatment with granulocyte-macrophage colony-stimulating factor. , 1996, Cancer research.

[17]  H. S. de Bruijn,et al.  Evidence for an important role of neutrophils in the efficacy of photodynamic therapy in vivo. , 1996, Cancer research.

[18]  W. Sluiter,et al.  Photodynamic treatment of human endothelial cells promotes the adherence of neutrophils in vitro. , 1996, British Journal of Cancer.

[19]  M. Korbelik,et al.  Induction of immune cell infiltration into murine SCCVII tumour by photofrin-based photodynamic therapy. , 1995, British Journal of Cancer.

[20]  Hanoch Kashtan,et al.  Photodynamic therapy of colorectal cancer using a new light source: from in vitro studies to a patient treatment , 1995, Other Conferences.

[21]  E. Waterfield,et al.  Accelerated myelopoietic recovery in irradiated mice treated with Photofrin. , 1995, International journal of immunopharmacology.

[22]  M. Colombo,et al.  Regression of an established tumor genetically modified to release granulocyte colony-stimulating factor requires granulocyte-T cell cooperation and T cell-produced interferon gamma , 1993, The Journal of experimental medicine.

[23]  H. Pass,et al.  Photodynamic therapy in oncology: mechanisms and clinical use. , 1993, Journal of the National Cancer Institute.

[24]  T. Dougherty Photodynamic therapy. , 1993, Photochemistry and photobiology.

[25]  P B Cerrito,et al.  The role of microvascular damage in photodynamic therapy: the effect of treatment on vessel constriction, permeability, and leukocyte adhesion. , 1992, Cancer research.

[26]  T. Dougherty,et al.  HOW DOES PHOTODYNAMIC THERAPY WORK? , 1992, Photochemistry and photobiology.

[27]  T. Foster,et al.  Photosensitized release of von Willebrand factor from cultured human endothelial cells. , 1991, Cancer research.

[28]  U. Nseyo,et al.  Urinary cytokines following photodynamic therapy for bladder cancer. A preliminary report. , 1990, Urology.

[29]  F. Martin,et al.  Non-activated rat neutrophils kill syngeneic colon tumor cells by the release of a low molecular weight factor. , 1990, Immunobiology.

[30]  I Rosenthal,et al.  Release of clotting factors from photosensitized endothelial cells: A possible trigger for blood vessel occlusion by photodynamic therapy , 1988, FEBS letters.